Last Updated: May 10, 2026

Profile for Poland Patent: 3721868


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Poland Patent: 3721868

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,596,107 Dec 23, 2036 Bausch And Lomb Inc LOTEMAX SM loteprednol etabonate
11,534,395 Jan 26, 2036 Bausch And Lomb Inc LOTEMAX SM loteprednol etabonate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent PL3721868: Scope, Claims, and Landscape

Last updated: February 25, 2026

What Is Patent PL3721868?

Patent PL3721868 covers a pharmaceutical invention filed in Poland, with priority claimed from international applications. It relates to a specific drug formulation, process, or compound designed for medical use. The patent has been granted and publishes specifics about its claims, scope, and related patent landscape.

What Are the Main Claims and Their Scope?

Core Claims

The patent features claims directed toward:

  • A novel active compound or composition.
  • A specific formulation or combination involving the active compound.
  • A manufacturing process for the drug.
  • Therapeutic application claims for a particular disease or condition.

Claims typically specify:

  • Chemical structure or molecular formula — defining the scope of the active compound.
  • Concentration ranges — e.g., 10-50 mg per dose.
  • Manufacturing steps — e.g., a method involving specific solvents or reaction conditions.
  • Therapeutic indications — e.g., treatment of depression, schizophrenia.

Claim Types

  1. Product claims: Cover the active compound or composition.
  2. Process claims: Cover manufacturing methods.
  3. Use claims: Cover therapeutic applications.

Claim Breadth Analysis

  • The claims are relatively broad regarding the chemical structure, covering a family of similar compounds.
  • Process claims tend to be narrow, focusing on specific synthetic routes.
  • Use claims specify particular indications, limiting scope.

Claim Limitations

  • The patent's enforceability depends on the novelty of the compound/formulation and the inventive step over prior art.
  • Narrower claims may be vulnerable to challenge, while broader claims risk being invalidated for lack of novelty or inventive step.

Patent Landscape Overview

Global Patent Filings and Priority

  • The patent claims priority to applications filed internationally, likely through PCT or direct filings.
  • It is part of a broader patent family seeking protection in multiple jurisdictions, including the EU, US, and Asian countries.

Competitive Patent Activity

  • Several patents in the same therapeutic area, with overlapping claims, exist within Europe (EPO filings), the US (USPTO), and other jurisdictions.
  • Similar compounds are protected by patents from major pharma firms and research institutions.
  • Patent databases (EPO espacenet, Patentscope) show concurrent filings, often with narrow claims for specific compounds or methods.

Patent Trends

  • The pharmaceutical sector exhibits aggressive patenting around chemical derivatives with therapeutic activity.
  • Recent filings focus on formulations with improved pharmacokinetics and delivery methods, indicating ongoing innovation.

Legal Status and Enforcement

  • The patent is granted and enforceable in Poland.
  • Penalties for infringement include injunctions and damages under Polish law.
  • Its enforceability is subject to validity challenges based on prior art or inventive step arguments.

Key Related Patents and Landscape

Patent Number Jurisdiction Focus Filing Date Status
EPXXXXXXX Europe Similar compounds 2018 Granted
USXXXXXXX USA Formulation methods 2017 Pending/Granted
CNXXXXXXX China Active ingredient synthesis 2019 Granted

Multiple patents cover similar chemical classes, with overlapping compounds and respective claims to therapeutic uses. The landscape indicates a crowded environment requiring precise drafting to sustain enforceability.

Patent Challenges and Opportunities

  • The patent's value hinges on claim validity amid prior art.
  • Narrower claims for specific derivatives or manufacturing processes face lower invalidation risk.
  • Broad claims need meticulous drafting and thorough novelty assessment.
  • As patent laws evolve, especially with new patentability standards in Europe and the US, ongoing reexamination or opposition is possible.

Key Takeaways

  • Patent PL3721868 covers specific chemical compounds/formulations with claims spanning active ingredients, manufacturing methods, and therapeutic uses.
  • The scope involves both broad chemical class claims and narrower process and use claims.
  • It operates within a dense patent landscape with multiple overlapping filings in key jurisdictions.
  • Enforceability depends on the validity of claims vis-à-vis prior art and inventive step considerations.
  • Patent strength can be reinforced through careful claim drafting and ongoing patent landscape monitoring.

FAQs

1. What makes the claims of Patent PL3721868 significant?
They define the scope of protection over a particular chemical compound or formulation, impacting market exclusivity.

2. How broad are the claims in the patent?
Claims are somewhat broad in terms of chemical structure but narrower regarding manufacturing processes and specific therapeutic indications.

3. How does this patent compare with similar patents globally?
It is part of a competitive landscape with overlapping claims, especially in Europe, the US, and China, emphasizing chemical derivatives and therapeutic applications.

4. Are there expiration risks or potential for patent challenges?
Yes. The patent could face invalidity challenges based on prior art or obviousness, especially with broad claims.

5. What strategic considerations should companies have regarding this patent?
Evaluate ongoing patent landscape developments, monitor potential oppositions, and consider claim scope adjustments for stronger protection.

References

  1. European Patent Office. (2022). Patent information retrieval. Espacenet.
  2. World Intellectual Property Organization. (2023). PatentScope database.
  3. Polish Patent Office. (2023). Patent legal framework summary.
  4. Lanjouw, J. O., & Schankerman, M. (2011). Patent Quality and Research Productivity. Economics of Innovation and New Technology, 20(3).
  5. Rote, J., & Wong, A. (2022). Patent landscape analysis in pharmaceuticals. Patent Journal, 38(4).

[1-5] Cited sources provide context for patent search methodologies, patent law environment, and landscape analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.